Researchers use a novel process involving engineered Escherichia coli to turn plastic waste into levodopa, a frontline ...

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...

Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...

Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...

Drinking water sourced from newer groundwater or carbonate aquifers is linked to a significantly increased risk for Parkinson’s disease, a new study shows.

From standard medications to advanced drug delivery, surgery, and regenerative approaches, Parkinson's treatment options in ...

Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a Phase 3 clinical-stage biotechnology company developing the ...

NeuroRPM, a digital health company focused on Parkinson’s disease monitoring, today announced that its FDA-cleared wearable platform will be used for digital biomarker monitoring in Annovis Bio’s ANVS ...

A boxing class in Baltimore is helping people living with Parkinson's disease make connections in more ways than one.

A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with ...

Researchers have investigated how the geological source and age of groundwater, which supplies our drinking water systems, might be linked to Parkinson's disease. Scientists conducted this ...

Opinion editor’s note: Strib Voices publishes a mix of commentary online and in print each day. To contribute, click here. •• ...